Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-03-01 Purchase |
2024-03-05 4:58 pm |
Aclaris Therapeutics Inc. | ACRS | Powell Andrew Kenneth William Director |
14,500 | $1.2383 | $17,955 | 28,863 (Direct) |
View |
| 2023-10-23 Sale |
2023-10-25 4:28 pm |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
6,000 | $5.0767 | $30,460 | 129,917 (Indirect Direct) |
View |
| 2023-09-06 Purchase |
2023-09-07 4:16 pm |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
9,490 | $7.9 | $74,971 | 15,461 (Direct) |
View |
| 2023-08-28 Purchase |
2023-08-28 4:39 pm |
Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer |
14,705 | $6.7976 | $99,959 | 21,688 (Direct) |
View |
| 2023-08-21 Sale |
2023-08-22 4:31 pm |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
6,000 | $7.3158 | $43,895 | 135,917 (Indirect Direct) |
View |
| 2023-06-20 Sale |
2023-06-22 4:30 pm |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
6,000 | $10.28 | $61,663 | 141,917 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-01 Tax Withholding |
2024-06-04 4:30 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO |
2,722 | $1.03 | 1,403,249 (Direct) |
View |
| 2024-06-01 Exercise |
2024-06-04 4:30 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO |
9,466 | $0 | 1,403,249 (Direct) |
View |
| 2024-06-01 Exercise |
2024-06-04 4:30 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Reasons Bryan M. Director |
4,660 | $0 | 28,732 (Direct) |
View |
| 2024-06-01 Exercise |
2024-06-04 4:30 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Powell Andrew Kenneth William Director |
4,660 | $0 | 33,523 (Direct) |
View |
| 2024-06-01 Exercise |
2024-06-04 4:30 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director |
4,660 | $0 | 53,163 (Direct) |
View |
| 2024-06-01 Exercise |
2024-06-04 4:30 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | MILANO VINCENT Director |
4,660 | $0 | 12,523 (Direct) |
View |
| 2024-06-01 Exercise |
2024-06-04 4:30 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Humphries William D. Director |
4,660 | $0 | 28,732 (Direct) |
View |
| 2024-06-01 Exercise |
2024-06-04 4:30 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director |
4,660 | $0 | 16,961 (Direct) |
View |
| 2024-06-01 Exercise |
2024-06-04 4:30 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director |
4,660 | $0 | 43,364 (Direct) |
View |
| 2024-06-01 Exercise |
2024-06-04 4:30 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director |
4,660 | $0 | 443,622 (Direct) |
View |
| 2024-05-01 Tax Withholding |
2024-05-03 4:20 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO |
2,784 | $1.26 | 1,405,971 (Direct) |
View |
| 2024-05-01 Exercise |
2024-05-03 4:20 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO |
9,467 | $0 | 1,405,971 (Direct) |
View |
| 2024-04-01 Tax Withholding |
2024-04-03 5:00 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO |
3,224 | $1.26 | 1,408,755 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-03 5:00 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal INTERIM PRESIDENT AND CEO |
9,467 | $0 | 1,408,755 (Direct) |
View |
| 2024-03-01 Exercise |
2024-03-05 5:08 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal Interim President and CEO |
9,466 | $0 | 1,411,979 (Direct) |
View |
| 2024-03-01 Tax Withholding |
2024-03-05 5:08 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal Interim President and CEO |
3,223 | $1.24 | 1,411,979 (Direct) |
View |
| 2024-03-01 Exercise |
2024-03-05 5:04 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
73,425 | $0 | 258,826 (Direct) |
View |
| 2024-03-01 Tax Withholding |
2024-03-05 5:04 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
21,283 | $1.24 | 258,826 (Direct) |
View |
| 2024-03-01 Exercise |
2024-03-05 5:02 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
4,975 | $0 | 29,833 (Direct) |
View |
| 2024-03-01 Tax Withholding |
2024-03-05 5:02 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
1,417 | $1.24 | 29,833 (Direct) |
View |
Ownership |
2024-02-08 10:47 am |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Leonard Braden Michael 10% Owner |
0 | $0 | 9,395,934 (Indirect) |
View |
| 2024-02-01 Option Award |
2024-02-05 7:36 pm |
N/A 2034-01-31 |
Aclaris Therapeutics Inc. | ACRS | Walker Neal Interim CEO |
639,000 | $0 | 639,000 (Direct) |
View |
| 2024-02-01 Tax Withholding |
2024-02-05 7:31 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
2,583 | $1.2 | 570,334 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 7:31 pm |
N/A 2034-01-31 |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
413,000 | $0 | 570,334 (Direct) |
View |
| 2024-02-01 Exercise |
2024-02-05 7:31 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
7,500 | $0 | 570,334 (Direct) |
View |
| 2024-02-01 Tax Withholding |
2024-02-05 7:29 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer |
6,421 | $1.2 | 492,017 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 7:29 pm |
N/A 2034-01-31 |
Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer |
413,000 | $0 | 492,017 (Direct) |
View |
| 2024-02-01 Exercise |
2024-02-05 7:29 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer |
18,750 | $0 | 492,017 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 7:27 pm |
N/A 2034-01-31 |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
413,000 | $0 | 413,000 (Direct) |
View |
| 2024-01-01 Tax Withholding |
2024-01-03 4:47 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
2,536 | $1.05 | 42,925 (Direct) |
View |
| 2024-01-01 Exercise |
2024-01-03 4:47 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
7,500 | $0 | 42,925 (Direct) |
View |
| 2024-01-01 Tax Withholding |
2024-01-03 4:44 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Manion Douglas J. Pres and CEO |
9,125 | $1.05 | 122,813 (Direct) |
View |
| 2024-01-01 Exercise |
2024-01-03 4:44 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Manion Douglas J. Pres and CEO |
27,000 | $0 | 122,813 (Direct) |
View |
| 2023-09-01 Exercise |
2023-09-05 5:08 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
1,000 | $0 | 6,971 (Direct) |
View |
| 2023-09-01 Tax Withholding |
2023-09-05 5:08 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
285 | $7.9 | 6,971 (Direct) |
View |
| 2023-08-01 Exercise |
2023-08-03 4:24 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Manion Douglas J. Pres and CEO |
15,575 | $0 | 70,663 (Direct) |
View |
| 2023-08-01 Tax Withholding |
2023-08-03 4:24 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Manion Douglas J. Pres and CEO |
4,437 | $9.81 | 70,663 (Direct) |
View |
| 2023-07-01 Exercise |
2023-07-05 4:23 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Cawkwell Gail Chief Medical Officer |
15,000 | $0 | 54,593 (Direct) |
View |
| 2023-07-01 Tax Withholding |
2023-07-05 4:23 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Cawkwell Gail Chief Medical Officer |
5,407 | $10.37 | 54,593 (Direct) |
View |
| 2023-06-20 Exercise |
2023-06-22 4:32 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director |
16,500 | $1.41 | 48,503 (Direct) |
View |
| 2023-06-20 Exercise |
2023-06-22 4:32 pm |
N/A 2030-06-03 |
Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director |
16,500 | $0 | 48,503 (Direct) |
View |
| 2023-06-15 Exercise |
2023-06-20 4:31 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director |
51 | $0.72 | 32,003 (Direct) |
View |
| 2023-06-15 Exercise |
2023-06-20 4:31 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director |
198 | $1.52 | 32,003 (Direct) |
View |
| 2023-06-15 Exercise |
2023-06-20 4:31 pm |
N/A 2024-08-12 |
Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director |
249 | $0 | 32,003 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 5:12 pm |
N/A 2033-05-31 |
Aclaris Therapeutics Inc. | ACRS | Humphries William D. Director |
20,410 | $0 | 44,482 (Direct) |
View |
| 2023-06-02 Exercise |
2023-06-05 5:12 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Humphries William D. Director |
4,507 | $0 | 44,482 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 5:08 pm |
N/A 2033-05-31 |
Aclaris Therapeutics Inc. | ACRS | MILANO VINCENT Director |
20,410 | $0 | 28,273 (Direct) |
View |
| 2023-06-02 Exercise |
2023-06-05 5:08 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | MILANO VINCENT Director |
4,507 | $0 | 28,273 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 5:04 pm |
N/A 2033-05-31 |
Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director |
20,410 | $0 | 32,711 (Direct) |
View |
| 2023-06-02 Exercise |
2023-06-05 5:04 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director |
4,507 | $0 | 32,711 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 5:02 pm |
N/A 2033-05-31 |
Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director |
20,410 | $0 | 52,164 (Direct) |
View |
| 2023-06-02 Exercise |
2023-06-05 5:02 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director |
4,507 | $0 | 52,164 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 4:57 pm |
N/A 2033-05-31 |
Aclaris Therapeutics Inc. | ACRS | Reasons Bryan M. Director |
20,410 | $0 | 44,482 (Direct) |
View |
| 2023-06-02 Exercise |
2023-06-05 4:57 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Reasons Bryan M. Director |
4,507 | $0 | 44,482 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 4:53 pm |
N/A 2033-05-31 |
Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director |
20,410 | $0 | 459,372 (Direct) |
View |
| 2023-06-02 Exercise |
2023-06-05 4:53 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director |
4,507 | $0 | 459,372 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 4:50 pm |
N/A 2033-05-31 |
Aclaris Therapeutics Inc. | ACRS | Powell Andrew Kenneth William Director |
20,410 | $0 | 34,773 (Direct) |
View |
| 2023-06-02 Exercise |
2023-06-05 4:50 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Powell Andrew Kenneth William Director |
4,507 | $0 | 34,773 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 4:45 pm |
N/A 2033-05-31 |
Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director |
20,410 | $0 | 59,114 (Direct) |
View |
| 2023-06-02 Exercise |
2023-06-05 4:45 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director |
4,507 | $0 | 59,114 (Direct) |
View |